Results
1375
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1375 companies
Pulike Biological Engineering
Market Cap: CN¥4.7b
Engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs.
603566
CN¥13.64
7D
-2.0%
1Y
5.2%
Viva Biotech Holdings
Market Cap: HK$5.1b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$2.41
7D
-6.6%
1Y
213.0%
PEPTONIC medical
Market Cap: €560.2m
A pharmaceutical company, researches, develops, and sells medical treatments and lifestyle products in the field of women's health.
28L
€0.0002
7D
0%
1Y
0%
KalVista Pharmaceuticals
Market Cap: US$653.3m
A biopharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.
KALV
US$12.10
7D
-12.9%
1Y
21.0%
Beijing Kawin Technology Share-Holding
Market Cap: CN¥4.6b
A biopharmaceutical company, provides treatment solutions for viral and immune diseases in China.
688687
CN¥27.63
7D
-5.9%
1Y
16.8%
Tempo Scan Pacific
Market Cap: Rp10.7t
Engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally.
TSPC
Rp2,410.00
7D
1.7%
1Y
-13.6%
Daewoong
Market Cap: ₩901.6b
Engages in the manufacture and sale of pharmaceuticals in South Korea.
A003090
₩22,050.00
7D
-7.2%
1Y
-7.9%
SIGA Technologies
Market Cap: US$638.0m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$8.78
7D
-1.0%
1Y
26.5%
Yabao Pharmaceutical Group
Market Cap: CN¥4.6b
Researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally.
600351
CN¥6.50
7D
-2.4%
1Y
11.3%
Supriya Lifescience
Market Cap: ₹56.5b
Engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.
SUPRIYA
₹702.00
7D
-3.3%
1Y
24.4%
SNDL
Market Cap: US$633.1m
Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.
SNDL
US$2.33
7D
-5.7%
1Y
15.3%
TTY Biopharm
Market Cap: NT$19.3b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$77.70
7D
1.7%
1Y
5.0%
AIM Vaccine
Market Cap: HK$4.9b
Engages in the research and development, manufacture, and sale of vaccine products for human use in the People’s Republic of China.
6660
HK$3.99
7D
-8.7%
1Y
-30.2%
Shanghai Hile Bio-Technology
Market Cap: CN¥4.5b
Researches, develops, produces, and sells veterinary biological products for livestock and poultry in China.
603718
CN¥6.79
7D
-3.0%
1Y
0.3%
Ginkgo Bioworks Holdings
Market Cap: US$623.5m
Develops a platform for cell programming in the United States.
DNA
US$11.50
7D
1.1%
1Y
42.2%
Zeria Pharmaceutical
Market Cap: JP¥92.7b
Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.
4559
JP¥2,103.00
7D
0.3%
1Y
-6.8%
AnaptysBio
Market Cap: US$617.1m
A clinical-stage biotechnology company, focuses in delivering immunology therapeutics.
ANAB
US$23.58
7D
13.1%
1Y
-26.0%
Bicara Therapeutics
Market Cap: US$610.6m
A clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors.
BCAX
US$10.70
7D
-3.3%
1Y
-58.4%
ZhuZhou QianJin PharmaceuticalLtd
Market Cap: CN¥4.3b
Researches, produces, and sells Chinese patent medicines, chemical medicines, and feminine hygiene products in China.
600479
CN¥10.37
7D
-1.5%
1Y
-1.4%
Adcock Ingram Holdings
Market Cap: R10.5b
Engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India.
AIP
R71.85
7D
-0.07%
1Y
3.1%
Lifecome BiochemistryLtd
Market Cap: CN¥4.3b
Operates as a biopharmaceutical company in China.
002868
CN¥27.54
7D
-0.07%
1Y
98.3%
Medy-Tox
Market Cap: ₩846.5b
Operates as a biopharmaceutical company in South Korea.
A086900
₩120,600.00
7D
-5.8%
1Y
-35.6%
Organogenesis Holdings
Market Cap: US$593.7m
A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
ORGO
US$4.10
7D
-10.5%
1Y
41.9%
Zhuhai Rundu Pharmaceutical
Market Cap: CN¥4.2b
Develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, and CNS worldwide.
002923
CN¥12.64
7D
-6.0%
1Y
41.7%
Zhejiang Yatai Pharmaceutical
Market Cap: CN¥4.2b
Researches, produces, sells, and exports pharmaceutical products in China and internationally.
002370
CN¥5.67
7D
-3.1%
1Y
87.7%
Boiron
Market Cap: €507.0m
Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.
BOI
€29.15
7D
-0.2%
1Y
-8.8%
KYORIN Pharmaceutical
Market Cap: JP¥87.7b
Through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally.
4569
JP¥1,527.00
7D
1.1%
1Y
-0.3%
Hvsen Biotechnology
Market Cap: CN¥4.2b
Engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally.
300871
CN¥20.68
7D
-2.6%
1Y
122.6%
DongKook Pharmaceutical
Market Cap: ₩819.9b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩18,470.00
7D
-6.7%
1Y
8.7%
Zhejiang Cheng Yi Pharmaceutical
Market Cap: CN¥4.1b
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
603811
CN¥12.93
7D
-4.2%
1Y
85.0%
Oruka Therapeutics
Market Cap: US$571.9m
A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.
ORKA
US$15.05
7D
-9.2%
1Y
-37.0%
Arvinas
Market Cap: US$569.0m
A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.
ARVN
US$8.27
7D
10.0%
1Y
-66.6%
Getein Biotech
Market Cap: CN¥4.1b
Researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally.
603387
CN¥8.00
7D
-2.7%
1Y
-3.4%
Olema Pharmaceuticals
Market Cap: US$562.1m
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.
OLMA
US$9.51
7D
16.4%
1Y
-22.0%
Medtide
Market Cap: HK$4.3b
A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.
3880
HK$30.60
7D
0%
1Y
n/a
Swedencare
Market Cap: SEK 5.3b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 33.75
7D
-3.3%
1Y
-22.2%